Daye’s Post

Calling all DC based diagnostics technology enthusiasts! If you're also going to Next Generation Dx Summit, please stop by our presentation on August 21st and learn more about the clinical evidence behind Daye's Diagnostic Tampon for HPV screening. #Diagnostics #STIs #HPV #CervicalCancer #ClinicalTrials

T-2 days to go. 🔔 Clinicians, we’re only halfway through the tick season 🦠, you sure don’t want to miss our upcoming webinar "Navigating the Complexities of Lyme Disease: Challenges and Controversies" on Friday, July 12th at 1:00pm EST. Our distinguished panel members will discuss controversies, diagnosis, treatment challenges, common misconceptions and best practices to confidently manage Lyme disease cases. Limited spots, register now: https://bit.ly/3z9bWtt #LymeDisease #epocrates #Webinar #WebinarAlert

Interesting read

HCPs, is Lyme disease 🦠 season leaving you with more questions than answers? Join our upcoming webinar, "Navigating the Complexities of Lyme Disease: Challenges and Controversies" on July 12th from 1:00-1:30pm EST. Our panel of experts will speak on controversies, diagnosis, treatment challenges, common misconceptions, and best practices to confidently manage cases in your practice. Register now: https://bit.ly/3z9bWtt #LymeDisease #epocrates #Webinar #WebinarAlert

📢 Exciting Update from #MDSCongress2024! We're thrilled to share our preliminary findings on the efficacy of smartphone-based at-home testing for sensitively tracking disease progression in #ParkinsonsDisease, even when participants are on stable dopaminergic therapy. Key contributors to this research include: Florian Lipsmeier, Stefan Lambrecht, Stefan Frässle, Yulia Gazizova, Damian Kwaśny, Bernhard Fehlmann, Thomas Kustermann, Michael Lindemann, Werner Popp, Kirsten Taylor, and Ron Postuma. 📍 Want to learn more? Visit our poster session at the congress (Sunday 29/9), or Contact me directly for detailed insights. #DigitalHealth #DigitalBiomarkers #ParkinsonsResearch

Did you miss our webinar focused on shortening the rare disease diagnostic odyssey leveraging genetic testing lab data for commercial analytics? Please register to view the recording and learn the latest from our expert partners Genedx and Pharming.

#Publication alert #SCIE #Natures#Scientific_Reports Our collaborative work with Md. Mehedi Hassan and Amir H Gandomi  is now online for exploring the latest paradigm shift in Heart disease diagnosis with look of Attention based mechanism and GRU involvement.

Recruiting for rare disease studies brings unique challenges—but they're challenges we love to tackle! 💪 From finding small, scattered patient populations 🌍 to overcoming limited awareness and access 🏥, we overcome these hurdles every day to support critical research. At PatientWing, we’re committed to making a difference for patients and sponsors alike. Need help with your rare disease study? Let’s talk! #RareDiseaseEnrollment #PatientRecruitment #PatientWing

The Undiagnosed Day, hosted by the Wilhelm Foundation, the @Undiagnosed Diseases Network Foundation (UDNF), and Undiagnosed Diseases Network International (UDNI), will include presentations from Global experts highlighting the great work which is being done across the globe focusing on improving the diagnostic odyssey for the undiagnosed and ultra-rare disease communities. This year’s theme, Building the Undiagnosed Community: Global Perspectives and Shared Action, aims to highlight the importance of fostering international collaboration and addressing the unique needs of undiagnosed communities worldwide, including the 1 in 10 Americans living with an undiagnosed, ultra-rare, or rare disease. Speakers will include patients, caregivers, clinicians, researchers, and other stakeholders providing information and updates about the various programs and initiatives in the US and across the globe. Visit https://lnkd.in/grqXDAAS to learn more, review the agenda and register! #UndiagnosedDay2024

💡👩⚕️ Join Pam Ventola in Cogstate's upcoming webinar as she delves into innovative strategies for adapting endpoints in rare disease trials. Discover how sponsors can tailor both standardized measures like Vineland-3 and clinician-reported outcomes such as CGI-S/I to suit the unique needs of patient populations. Additionally, explore rater training approaches and targeted data quality monitoring methodologies crucial for overcoming the challenges posed by diverse patient recruitment in rare disease studies. Don't miss out on these invaluable insights! 🔗 Register here: https://buff.ly/426ENsW #RareDisease #ClinicalResearch #PatientRecruitment #ClinicalData